Search results for: 'research area cell cycle c myc'
-
R1033 EZ Cap™ Mouse p53 mRNA (ψUTP)Summary: Mouse p53 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1034 EZ Cap™ Mouse p53 mRNA (5-moUTP)Summary: Mouse p53 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-
R1035 EZ Cap™ Fdx1 mRNASummary: Fdx1 mRNA with Cap 1 structure, providing high transcriptional efficiency
-
R1036 EZ Cap™ Fdx1 mRNA (ψUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-
R1037 EZ Cap™ Fdx1 mRNA (5-moUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-
R1047 EZ Cap™ mCherry mRNA (m1Ψ)Summary: mCherry mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-
R1038 EZ Cap™ Human P16 mRNASummary: Human p16 mRNA with Cap 1 structure, providing high transcriptional efficiency
-
R1039 EZ Cap™ Human P16 mRNA (ψUTP)Summary: Human p16 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-
R1040 EZ Cap™ Human P16 mRNA (5-moUTP)Summary: Human p16 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-
R1041 EZ Cap™ Mouse P16 mRNASummary: Mouse p16 mRNA with Cap 1 structure, providing high transcriptional efficiency